INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
EXPERT REPORT by HEDLEY REES, PHARMAFLOW, DATED 17th DECEMBER 2021 - PART II

EXPERT REPORT by HEDLEY REES, PHARMAFLOW, DATED 17th DECEMBER 2021 - PART II

Contract manufactures, MHRA lack of competency, Novartis' Kymriah gene therapy

Hedley Rees's avatar
Hedley Rees
Oct 18, 2024
∙ Paid
5

Share this post

INSIDE PHARMA
INSIDE PHARMA
EXPERT REPORT by HEDLEY REES, PHARMAFLOW, DATED 17th DECEMBER 2021 - PART II
2
Share

EXPERT REPORT, PART II

You will, hopefully, remember this from yesterday:

EXPERT REPORT by HEDLEY REES, PHARMAFLOW, DATED 17th DECEMBER 2021 - PART I

EXPERT REPORT by HEDLEY REES, PHARMAFLOW, DATED 17th DECEMBER 2021 - PART I

Hedley Rees
·
October 17, 2024
Read full story

For PART II, I have picked out some of the more relevant content that is educational plus, possibly, new information for you. Here you go:

A variety of companies are involved in the development and manufacture of COVID vaccines.  These include:

OXFORD BIOMEDICA

LONZA

COBRA BIOLOGICS

WOCKHARDT

CATALENT PHARMA SOLUTIONS

[Note from Hedley - LONZA and CATALENT produced the Moderna injections. Moderna would not have had a clue how to do it. UK Government has since began building Moderna production facilities in the UK]

Conflicts of Interest and lack of experience in the MHRA

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share